Literature DB >> 31359845

Adult Mice Lacking Mct8 and Dio2 Proteins Present Alterations in Peripheral Thyroid Hormone Levels and Severe Brain and Motor Skill Impairments.

Soledad Bárez-López1,2, Carmen Grijota-Martínez1,2, Eva Ausó1,3, Mario Fernández-de Frutos1, Ana Montero-Pedrazuela1, Ana Guadaño-Ferraz1,2.   

Abstract

Background: Mutations in the thyroid hormone (TH) transporter monocarboxylate transporter 8 (MCT8) lead to peripheral hyperthyroidism and profound psychomotor alterations in humans. Mice lacking Mct8 present peripheral hyperthyroidism but no gross neurological abnormalities due to brain compensatory mechanisms involving the enzyme deiodinase type 2 (Dio2).
Methods: Here we have analyzed the endocrine and neurologic phenotype of mice lacking both Mct8 and Dio2 at three and six months of age. Thyroxine (T4) and 3,5,3' triiodothyronine (T3) levels/content were measured by specific radioimmunoassays; motor skill performance was evaluated by the footprint, rotarod, four limb hanging wire, and balance beam tests; and brain histological analysis was performed by immunostaining for neurofilament and parvalbumin.
Results: We have found that this mouse model presents peripheral hyperthyroidism and brain hypothyroidism. Interestingly, the severity of the brain hypothyroidism seems permanent and varies across regions, with the striatum being a particularly affected area. We have also found brain alterations at the histological level compatible with TH deficiency and impaired motor skills. Conclusions: These findings indicate the potential of Mct8/Dio2-deficient mice to represent a model for human MCT8 deficiency, to understand the mechanisms underlying its pathophysiology, and ultimately design therapeutic interventions for human patients.

Entities:  

Keywords:  Mct8 deficiency; deiodinase type 2; histological brain impairments; motor skills impairments; mouse model

Year:  2019        PMID: 31359845     DOI: 10.1089/thy.2019.0068

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  12 in total

1.  Thyroid Disruptors: Extrathyroidal Sites of Chemical Action and Neurodevelopmental Outcome-An Examination Using Triclosan and Perfluorohexane Sulfonate.

Authors:  Mary E Gilbert; Katherine L O'Shaughnessy; Susan E Thomas; Cal Riutta; Carmen R Wood; Alicia Smith; Wendy O Oshiro; Richard L Ford; Michelle Gatien Hotchkiss; Iman Hassan; Jermaine L Ford
Journal:  Toxicol Sci       Date:  2021-08-30       Impact factor: 4.109

2.  AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency.

Authors:  Xiao-Hui Liao; Pablo Avalos; Oksana Shelest; Raz Ofan; Michael Shilo; Catherine Bresee; Shibi Likhite; Jean-Philippe Vit; Heike Heuer; Brian Kaspar; Kathrin Meyer; Alexandra M Dumitrescu; Samuel Refetoff; Clive N Svendsen; Gad D Vatine
Journal:  Thyroid       Date:  2022-05-20       Impact factor: 6.506

3.  Intranasal delivery of Thyroid hormones in MCT8 deficiency.

Authors:  Carmen Grijota-Martínez; Soledad Bárez-López; Eva Ausó; Samuel Refetoff; William H Frey; Ana Guadaño-Ferraz
Journal:  PLoS One       Date:  2020-07-20       Impact factor: 3.240

Review 4.  Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?

Authors:  Pieter Vancamp; Barbara A Demeneix; Sylvie Remaud
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-13       Impact factor: 5.555

5.  Intracerebroventricular administration of the thyroid hormone analog TRIAC increases its brain content in the absence of MCT8.

Authors:  Soledad Bárez-López; Carmen Grijota-Martínez; Xiao-Hui Liao; Samuel Refetoff; Ana Guadaño-Ferraz
Journal:  PLoS One       Date:  2019-12-06       Impact factor: 3.240

Review 6.  Thyroid Hormone Hyposensitivity: From Genotype to Phenotype and Back.

Authors:  Giuditta Rurale; Emery Di Cicco; Monica Dentice; Domenico Salvatore; Luca Persani; Federica Marelli; Cristina Luongo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-24       Impact factor: 5.555

Review 7.  Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development.

Authors:  Ferdy S van Geest; Nilhan Gunhanlar; Stefan Groeneweg; W Edward Visser
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

Review 8.  MCT8 Deficiency: The Road to Therapies for a Rare Disease.

Authors:  Carmen Grijota-Martínez; Soledad Bárez-López; David Gómez-Andrés; Ana Guadaño-Ferraz
Journal:  Front Neurosci       Date:  2020-04-28       Impact factor: 4.677

9.  Moderate SIRT1 overexpression protects against brown adipose tissue inflammation.

Authors:  Carmen Escalona-Garrido; Patricia Vázquez; Paula Mera; Sebastián Zagmutt; Ester García-Casarrubios; Ana Montero-Pedrazuela; Fernanda Rey-Stolle; Ana Guadaño-Ferraz; Francisco J Rupérez; Dolors Serra; Laura Herrero; Maria Jesus Obregon; Ángela M Valverde
Journal:  Mol Metab       Date:  2020-10-10       Impact factor: 7.422

Review 10.  Congenital Hypothyroidism and Brain Development: Association With Other Psychiatric Disorders.

Authors:  Katsuya Uchida; Mao Suzuki
Journal:  Front Neurosci       Date:  2021-12-09       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.